ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy

PILAR FONT UGALDEEDUARDO COLLANTES ESTÉVEZ2026-01-292026-01-29201410.1016/j.reuma.2013.12.0062-s2.0-84902801514https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/25466RheumatologyRheumatologyASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapyresearch article